Friday, December 08, 2017 6:55:05 PM
Unless Howe comes out with a ridiculously convincing argument after the settlement for why JNSH remains completely tight-lipped about its future plans, I'll likely be moving on.
No, uplisting to NASDAQ isn't realistic as of right now.
I can't invest in an OTC company for years on end if they can't at least forecast realistic goals. The settlement/jury decision is the only thing that must happen; literally everything else is purely speculative because there's been no mention of it from JNSH.
I'd like to believe the story; they've definitely done a great job stabilizing the company, streamlining operations, and showing modest growth. That's the hallmark of a steady CEO, but not necessarily one that can take the next step.
Which is fine. I applaud JNSH for it. But that alone doesn't warrant long-term investment; Howe doesn't need public investment to grow organically in the manner that he has, and so there's no incentive to convince shareholders of future ROI.
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM